Litcius/Paper detail

Adherence to tyrosine kinase inhibitor and clinical outcomes in patients with chronic myeloid leukemia

Fang Cheng, Zheng Cui, Qiang Li, Liu Wang, Weiming Li, Weiming Li

2023International Immunopharmacology13 citationsDOI

Topics & Concepts

MedicineMyeloid leukemiaInternal medicineTyrosine-kinase inhibitorRetrospective cohort studyMedication adherenceDasatinibOncologyImatinibCancerChronic Myeloid Leukemia TreatmentsMedication Adherence and ComplianceAdvanced Breast Cancer Therapies
Adherence to tyrosine kinase inhibitor and clinical outcomes in patients with chronic myeloid leukemia | Litcius